🇺🇸 Abobotulinumtoxin A in United States

15 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Eyelid Ptosis — 3 reports (20%)
  2. Dysphagia — 2 reports (13.33%)
  3. Fatigue — 2 reports (13.33%)
  4. Muscular Weakness — 2 reports (13.33%)
  5. Abortion Spontaneous — 1 report (6.67%)
  6. Drug Exposure During Pregnancy — 1 report (6.67%)
  7. Drug Ineffective — 1 report (6.67%)
  8. Dry Mouth — 1 report (6.67%)
  9. Dysphonia — 1 report (6.67%)
  10. Dyspnoea — 1 report (6.67%)

Source database →

Other Neurology approved in United States

Frequently asked questions

Is Abobotulinumtoxin A approved in United States?

Abobotulinumtoxin A does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Abobotulinumtoxin A in United States?

Neurology Center of New England P.C. is the originator. The local marketing authorisation holder may differ — check the official source linked above.